Literature DB >> 24881006

Persons with moderate Alzheimer's disease use simple technology aids to manage daily activities and leisure occupation.

Giulio E Lancioni1, Nirbhay N Singh2, Mark F O'Reilly3, Jeff Sigafoos4, Caterina Renna5, Katia Pinto6, Floriana De Vanna7, Alessandro O Caffò8, Fabrizio Stasolla9.   

Abstract

Two studies assessed technology-aided programs to support performance of daily activities and selection/activation of music items with patients with moderate Alzheimer's disease. In Study I, four patients were presented with activity-related pictorial instructions via a computer fitted with inexpensive, commercial software. In Study II, four patients were (a) presented with different music options and (b) allowed to select and activate the preferred option via a microswitch response. Study I showed that each patient learned to perform the two activities available with percentages of correct responses exceeding 85 by the end of the intervention. Study II showed that all patients learned to choose and activate music options. Psychology students, employed in a social validation check, scored the patients' behavior within the program better than their behavior in a control situation. The relevance and usability of simplified pictorial-instruction programs and music choice programs for patients with moderate Alzheimer's disease were discussed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Daily activities; Leisure; Music; Technology

Mesh:

Year:  2014        PMID: 24881006     DOI: 10.1016/j.ridd.2014.05.002

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  1 in total

1.  Patients with moderate Alzheimer's disease engage in verbal reminiscence with the support of a computer-aided program: a pilot study.

Authors:  Giulio E Lancioni; Nirbhay N Singh; Mark F O'Reilly; Jeff Sigafoos; Fiora D'Amico; Gabriele Ferlisi; Floriana Denitto; Floriana De Vanna; Marta Olivetti Belardinelli
Journal:  Front Aging Neurosci       Date:  2015-06-03       Impact factor: 5.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.